(Q62241543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Fungal infection in solid organ recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Manuel Cuenca-Estrella

series ordinal

4

object named as

Manuel Cuenca-Estrella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Jesús Fortún

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Isabel Ruiz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

Infectious Diseases and Clinical Microbiology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

30 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

49-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

Invasive fungal infections and antifungal therapies in solid organ transplant recipients.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

A review of critical periods for opportunistic infection in the new transplantation era.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Transmission ofHistoplasma capsulatumby Organ Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Risk factors for invasive aspergillosis in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Late-onset invasive aspergillosis in organ transplant recipients in the current era.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Post-transplant Colonization With Non-Aspergillus Molds and Risk of Development of Invasive Fungal Disease in Lung Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Incidence of zygomycosis in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Fungal infections after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Voriconazole in the treatment of invasive mold infections in transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Posaconazole as salvage therapy for zygomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Posaconazole prophylaxis in experimental systemic zygomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970082-4

7 January 2021

10.1016/S0213-005X(12)70082-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22542035%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference